Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (244) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (29) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Webcasts and audio (14) Apply Webcasts and audio filter
- Financial reports (13) Apply Financial reports filter
- Analyst (11) Apply Analyst filter
- Investor contact (5) Apply Investor contact filter
- Event (4) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Amendment of Short-Term Loan Facility into new Term Loan Facility With Oaktree
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse
Oxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 million
Oxford, UK – 14 November 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell thera
Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer
Oxford, UK – 22 November 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell thera
Oxford Biomedica Solutions forms new partnerships with three biotechnology companies
Agreements signed with three new partners, bringing the total number of new AAV customers in 2022 to four, ahead of original target
Oxford Biomedica to Present at 41st Annual J.P Morgan Healthcare Conference
Oxford, UK – 21 December 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell thera